Antimüllerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate
- 30 November 2006
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 86 (5), 1515-1517
- https://doi.org/10.1016/j.fertnstert.2006.03.047
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transitionMenopause, 2004
- Anti-Müllerian Hormone Serum Concentrations in Normoovulatory and Anovulatory Women of Reproductive AgeJournal of Clinical Endocrinology & Metabolism, 2004
- Elevated Serum Level of Anti-Mullerian Hormone in Patients with Polycystic Ovary Syndrome: Relationship to the Ovarian Follicle Excess and to the Follicular ArrestJournal of Clinical Endocrinology & Metabolism, 2003
- Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulationHuman Reproduction, 2003
- Antimüllerian hormone serum levels: a putative marker for ovarian agingFertility and Sterility, 2002
- Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulationHuman Reproduction, 2001
- Efficacy and safety of long-acting GnRH agonists inin vitrofertilization and embryo transferHuman Fertility, 2001
- Goserelin Acetate (Zoladex) with or without Hormone Replacement Therapy for the Treatment of EndometriosisFertility and Sterility, 1998
- High rates of pregnancy after long-term down-regulation of women with severe endometriosisAmerican Journal of Obstetrics and Gynecology, 1994
- Production of Anti-Müllerian Hormone: Another Homology between Sertoli and Granulosa CellsEndocrinology, 1984